Telcon RF Pharmaceutical Inc (200230) Stock Price & News

All values in KRW	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	10.03B	9.82B	13.32B	9.70B
Cost of goods sold	8.13B	7.46B	8.86B	7.99B
Cost of revenue	8.13B	7.46B	8.86B	7.99B
Research and development expenses	198.97M	200.93M	121.08M	158.40M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.54B	1.36B	1.21B	1.99B
Operating expense	2.29B	2.37B	1.84B	3.14B
Total operating expenses	10.43B	9.83B	10.70B	11.13B
Operating income	-396.84M	-8.66M	2.63B	-1.43B
Other non operating income	-6.00B	-869.79M	9.17B	18.61M
EBT including unusual items	-1.83B	-4.85B	9.85B	-11.47B
EBT excluding unusual items	-3.69B	-3.30B	8.87B	-1.71B
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	26.65M	234.90M	-117.50M	42.37M
Net income	-1.80B	-4.88B	9.85B	-11.47B
Net profit margin	-17.93%	-49.71%	73.94%	-118.22%
Earnings per share	-	-	-	-
Interest and investment income	177.06M	161.64M	187.99M	330.99M
Interest expense	-1.60B	-1.05B	-889.39M	-905.78M
Net interest expenses	-1.42B	-885.28M	-701.40M	-574.79M
Depreciation and amortization charges	89.94M	101.59M	101.59M	94.48M
EBITDA	711.96M	1.18B	4.05B	-246.72M
Gain or loss from assets sale	-	-486.92M	-	-34.99M

AI content may include mistakes. Learn more

Finance